No image published for this recall
Apo-fluoxetine: the impurities are out of specification and out of trend
Official notice
10 Apr 2026
Last checked
10 Apr 2026
An official Health Canada notice concerns Apo-fluoxetine: the impurities are out of specification and out of trend. The impurities are out of specification and out of trend in the affected lot. Published 2026-04-10.
What to do now
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Recall number
81883
Official notice
2026-04-10
The hazard
The hazard
The impurities are out of specification and out of trend in the affected lot.
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Follow the official notice if they match.
Lots
Other
Recall Numbers
Checked manually this time?
The app alerts you when a new official recall is published — no searching, no checking back.
Turn on recall alertsAffected products
Affected products
Product 1
Product 2
Risk / hazard
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected products were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: Apotex. Contact: the recalling firm if you have any questions about the recall.
Source & status
Source & status
Source
Tier
Category
Classification
App estimate
Recall details
Recall details
Recall number
Classification
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeRelated recalls
Apo-brimonidine-timop: the weight is out of specification in the affected lot.
5 Mar 2026Apo-candesartan: affected lots were manufactured using an active ingredient that was out of specification for dissolution
Apo-travoprost-timop pq: missing the documented justification for the results obtained.
Extra strength ibuprofen liquid gel capsules: presence of cloudy capsules in affected lots
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
a product listed in the official notice - safety alert
Apo-brimonidine-timop: the weight is out of specification in the affected lot.
Apo-candesartan: affected lots were manufactured using an active ingredient that was out of specification for dissolution
Apo-travoprost-timop pq: missing the documented justification for the results obtained.
Extra strength ibuprofen liquid gel capsules: presence of cloudy capsules in affected lots
Weekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 10 Apr 2026. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
